Gardiquimod (Standard)
Gardiquimod (Standard) is the analytical standard of Gardiquimod. This product is intended for research and analytical applications. Gardiquimod is an imidazoline TLR7/8 agonist. Gardiquimod inhibits HIV-1 infection of macrophages and activated peripheral blood mononuclear cells (PBMCs) . Gardiquimod specifically activates TLR7 at concentrations below 10 μM.
Product Specifications
CAS Number
1020412-43-4
UNSPSC
12352005
Target
Reference Standards; Toll-like Receptor (TLR)
Related Pathways
Immunology/Inflammation; Others
Field of Research
Cancer
Smiles
OC(C)(C)CN1C(CNCC)=NC2=C1C3=CC=CC=C3N=C2N
Molecular Formula
C17H23N5O
Molecular Weight
313.40
References & Citations
[1]Buitendijk M, et al. Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells. AIDS Res Hum Retroviruses. 2013 Jun;29 (6) :907-18.|[2]Zhou Z, et al. TLR7/8 agonists promote NK-DC cross-talk to enhance NK cell anti-tumor effects in hepatocellular carcinoma. Cancer Lett. 2015 Dec 28;369 (2) :298-306.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
67014-AAT 1 Plate
Cy3.5 Dye qPCR Calibration Plate *Optimized for ABI7500 Fast 96-Well*
Sign In for Pricing
View Details 
LC426838 20 µg
Mitofusin 2 (MFN2) (NM_001127660) Human Over-expression Lysate
Sign In for Pricing
View Details 
